Related Experiment Video
Updated: Jun 27, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse
Carmela Mennuni1, Stefano Ugel, Federica Mori
1Istituto di Ricerca di Biologia Molecolare, Pomezia, Italy.
Abstract:
The telomerase reverse transcriptase, TERT, is an attractive target for human cancer vaccination because its expression is reactivated in a conspicuous fraction of human tumors. Genetic vaccination with murine telomerase (mTERT) could break immune tolerance in different mouse strains and resulted in the induction of both CD4+ and CD8+ telomerase-specific T cells. The mTERT-derived immunodominant epitopes recognized by CD8+ T cells were further defined in these mouse strains and used to track immune responses. Antitumor efficacy of telomerase-based vaccination was investigated in two cancer models closely resembling human diseases: the TRAMP transgenic mice for prostate cancer and a carcinogen-induced model for colon cancer. TERT overexpression in tumor lesions was shown in both models by immunohistochemistry, thus reinforcing the similarity of these tumors to their human counterparts. Repeated immunizations with mTERT-encoding DNA resulted in a significant delay of tumor formation and progression in both the prostate cancer and the colon cancer models. Moreover, evaluation of the intratumoral infiltrate revealed the presence of telomerase-specific T cells in vaccinated mice. The safety of vaccination was confirmed by the absence of histomorphologic changes on postnecropsy analysis of several organs and lack of adverse effects on blood cell counts. These results indicate that TERT vaccination can elicit antigen-specific immunosurveillance and imply this antigen as a potential candidate for preventive cancer vaccines.
Insights
Cancer vaccination targeting telomerase reverse transcriptase (TERT) shows promise. DNA vaccination with murine TERT (mTERT) effectively delayed tumor growth in mouse models, inducing antigen-specific T cell responses with no observed adverse effects.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Telomerase reverse transcriptase (TERT) is reactivated in many human cancers, making it a potential target for cancer vaccines.
- Genetic vaccination using murine TERT (mTERT) can overcome immune tolerance and induce TERT-specific T cell responses.
Purpose of the Study:
- To investigate the antitumor efficacy and safety of TERT-based vaccination in preclinical cancer models.
- To evaluate the induction of immune responses following mTERT vaccination.
Main Methods:
- Utilized TRAMP transgenic mice for prostate cancer and a carcinogen-induced model for colon cancer.
- Administered repeated immunizations with mTERT-encoding DNA.
- Assessed tumor progression, immunohistochemistry for TERT expression, and intratumoral T cell infiltrates.
- Conducted postnecropsy analysis for safety assessment.
Main Results:
- Repeated mTERT DNA vaccination significantly delayed tumor formation and progression in both prostate and colon cancer models.
- TERT-specific CD4+ and CD8+ T cells were induced, and telomerase-specific T cells were found in tumor infiltrates of vaccinated mice.
- Vaccination demonstrated a good safety profile with no significant adverse effects or organ damage.
Conclusions:
- TERT vaccination elicits antigen-specific immunosurveillance and demonstrates significant antitumor efficacy in relevant preclinical models.
- TERT represents a promising candidate antigen for the development of preventive cancer vaccines.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Replicative Cell Senescence
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Telomeres and Telomerase
Tumor Immunotherapy
In-vitro Mutagenesis